|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Less: Income from discontinued operations, net of tax | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by continuing operating activities: | |||||
| Depreciation and amortization | |||||
| Debt financing fees | |||||
| Impairment of long-lived assets (Note 4) | |||||
| Write-off and impairment of patents | |||||
| Share-based payment compensation costs | |||||
| Other | |||||
| Amortization of right of use assets | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Lease liabilities | |||||
| Other non-current liabilities | |||||
| Total adjustments | |||||
| Net cash provided by continuing operating activities | |||||
| Proceeds from sale of common stock, net of costs | |||||
| Net cash provided by continuing financing activities | |||||
| Discontinued operations: | |||||
| Net cash used in operating activities | |||||
| Net cash provided by investing activities | |||||
| Net cash provided by financing activities | |||||
| Net cash used in discontinued operations | |||||
| Net increase in cash | |||||
| Cash and cash equivalents - continuing operations, beginning of period | |||||
| Cash and restricted cash - discontinued operations, beginning of period | |||||
| Total cash and restricted cash, end of period | |||||
| Total cash and cash equivalents, end of period | |||||
Loading...